Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06252779
What this trial is testing

Study on the Therapeutic Effect and Mechanism of Transcranial Plasma Stimulation in the Treatment of Chronic Insomnia

Who this might be right for
Chronic Insomnia Disorder
Qinying Ma 40
Not applicableStudy completedNCT07773324
What this trial is testing

Kinesio Taping After Platelet-Rich Plasma Treatment in Individuals With Knee Osteoarthritis

Who this might be right for
Osteoarthritis (OA) of the Knee
Agri Ibrahim Cecen University 60
Large-scale testing (Phase 3)Study completedNCT00708435
What this trial is testing

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Who this might be right for
Blood Coagulation DisordersAcute Major Bleeding
CSL Behring 216
Not applicableUnknownNCT04292340
What this trial is testing

Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

Who this might be right for
Coronavirus
Shanghai Public Health Clinical Center 15
Not applicableStudy completedNCT02520089
What this trial is testing

Humeral Shaft Pseudoarthrosis Treated With Bone Autograft Versus Platelet Rich Plasma

Who this might be right for
Pseudoarthrosis
Universidad Autonoma de Nuevo Leon 23
Testing effectiveness (Phase 2)Study completedNCT02858999
What this trial is testing

Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire, Amiens 40
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Not applicableStudy completedNCT07121647
What this trial is testing

Selective Plasmofiltration for Abdominal Septic Shock: a Clinical Ctudy

Who this might be right for
Selective Plasma Filtration
Pirogov Russian National Research Medical University 101
Testing effectiveness (Phase 2)Ended earlyNCT01484626
What this trial is testing

Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Loyola University 3
Post-approval studies (Phase 4)Ended earlyNCT00934635
What this trial is testing

A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

Who this might be right for
Schizophrenia
Janssen-Cilag G.m.b.H 2
Not applicableLooking for participantsNCT06463717
What this trial is testing

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

Who this might be right for
Multiple MyelomaMinimal Residual Disease
First Affiliated Hospital of Zhejiang University 210
Not applicableStudy completedNCT05046652
What this trial is testing

Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series

Who this might be right for
Infectious Disease
Maranatha Christian University 8
Testing effectiveness (Phase 2)UnknownNCT05501743
What this trial is testing

Evaluation of the Efficacy of an Intra-articular Injection of Autologous Microfat Combined With Autologous Platelet-enriched Plasma in the Treatment of Radiocarpal Osteoarthritis: a Randomized Controlled Non-inferiority Trial Versus Total Wrist Denervation (Established Standard Treatment).

Who this might be right for
Arthrosis
Assistance Publique Hopitaux De Marseille 36
Testing effectiveness (Phase 2)Looking for participantsNCT06500884
What this trial is testing

Evaluate Preventive Treatments for GPRC5D-related Oral Events

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 210
Testing effectiveness (Phase 2)Ended earlyNCT01720043
What this trial is testing

Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Utah 8
Testing effectiveness (Phase 2)Study completedNCT00095680
What this trial is testing

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Scios, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT04356482
What this trial is testing

CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19

Who this might be right for
COVID-19SARS-CoV 2Convalescence+2 more
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 90
Very early researchNot Yet RecruitingNCT07365059
What this trial is testing

Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders

Who this might be right for
Plasma Cell Dyscrasias
Qi deng 18
Testing effectiveness (Phase 2)Ended earlyNCT02020941
What this trial is testing

Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy

Who this might be right for
Refractory Multiple Myeloma
Attaya Suvannasankha 10
Testing effectiveness (Phase 2)Study completedNCT01056276
What this trial is testing

Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 59
Next Page